16.27
-0.24(-1.45%)
Currency In USD
| Previous Close | 16.51 |
| Open | 16.66 |
| Day High | 16.68 |
| Day Low | 15.69 |
| 52-Week High | 24.35 |
| 52-Week Low | 10.57 |
| Volume | 830,278 |
| Average Volume | 1.57M |
| Market Cap | 2.39B |
| PE | -5.57 |
| EPS | -2.92 |
| Moving Average 50 Days | 17.19 |
| Moving Average 200 Days | 15.09 |
| Change | -0.24 |
If you invested $1000 in Denali Therapeutics Inc. (DNLI) since IPO date, it would be worth $758.51 as of January 05, 2026 at a share price of $16.27. Whereas If you bought $1000 worth of Denali Therapeutics Inc. (DNLI) shares 5 years ago, it would be worth $231.63 as of January 05, 2026 at a share price of $16.27.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
GlobeNewswire Inc.
Dec 30, 2025 1:00 PM GMT
Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and normalization of liver volume Most common treatment-r
Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Dec 10, 2025 5:14 AM GMT
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common stock at a price to the public of $17.50 per sh
Denali Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Dec 09, 2025 9:01 PM GMT
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced that it intends to offer and sell $200 million of shares of its common stock and, in lieu of common stock to certain investors, p